Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

Por Godman, Brian, Malmström, Rickard E., Diogene, Eduardo, Jayathissa, Sisira, McTaggart, Stuart, Cars, Thomas, Alvarez-Madrazo, Samantha, Baumgärtel, Christoph, Brzezinska, Anna, Bucsics, Anna, Campbell, Stephen, Eriksson, Irene, Finlayson, Alexander, Fürst, Jurij, Garuoliene, Kristina, Gutiérrez-Ibarluzea, Iñaki, Hviding, Krystyna, Herholz, Harald, Joppi, Roberta, Kalaba, Marija, Laius, Ott, Malinowska, Kamila, Pedersen, Hanne B., Markovic-Pekovic, Vanda, Piessnegger, Jutta, Selke, Gisbert, Sermet, Catherine, Spillane, Susan, Tomek, Dominik, Vončina, Luka, Vlahović-Palčevski, Vera, Wale, Janet, Wladysiuk, Magdalena, van Woerkom, Menno, Zara, Corinne, Gustafsson, Lars L.
Publicado em 2014